Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England. by Paterson, P et al.
LSHTM Research Online
Paterson, P; Mounier-Jack, S; Saliba, V; Yarwood, J; White, J; Ramsay, M; Chantler, T; (2019)
Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adoles-
cent girls’ HPV vaccination programme in England. Journal of public health. ISSN 1741-3842 DOI:
https://doi.org/10.1093/pubmed/fdz061
Downloaded from: http://researchonline.lshtm.ac.uk/4653464/
DOI: https://doi.org/10.1093/pubmed/fdz061
Usage Guidelines:
Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
Journal of Public Health | pp. 1–8 | doi:10.1093/pubmed/fdz061
Strengthening HPV vaccination delivery: ﬁndings from a
qualitative service evaluation of the adolescent girls’ HPV
vaccination programme in England
P Paterson1, S Mounier-Jack2, V Saliba3, J Yarwood4, J White2, M Ramsay3, T Chantler2
1The Vaccine Conﬁdence Project, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK
2Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London WC1H 9SH, UK
3Immunisation, Hepatitis and Blood Safety Department, Public Health England, London NW9 5EQ, UK
4Immunisation, Hepatitis and Blood Safety Department, Public Health England, London SE1 8UG, UK
Address correspondence to Paterson P, E-mail: Pauline.paterson@lshtm.ac.uk
ABSTRACT
Background In 2014, the number of HPV vaccine doses given to adolescent girls as part of the English school-based immunization programme
was reduced from three to two. This was based on evidence that a two-dose schedule provides long-lasting protection against HPV infection. In
2015/16 a small decline in HPV vaccination coverage in adolescent girls was noted; from 86.7% for the three-dose schedule in 2013/14 to
85.1% for the two-dose schedule. This evaluation examined whether service-related factors contributed to this decline.
Methods In May–August 2017, we conducted semi-structured qualitative interviews with 39 participants responsible for commissioning or
delivering immunization programmes in six local authorities in the South West, North Central Midlands and South Central Midlands, England.
Results Effective planning and data management were key for successful service provision of HPV vaccination, as well as close collaboration
between commissioners, service providers and data system managers, a team skill mix with experienced staff, pro-active engagement with
schools and service providers equipped to respond to parental concerns.
Conclusions To maintain and improve the high HPV adolescent girls’ vaccine coverage rates achieved in England, in the context of an
expanding school-based immunization programme, it is essential to strengthen the organizational capacity of the delivery system.
Keywords England, qualitative research, HPV vaccine, school-based vaccination, vaccine delivery strategies
Introduction
A national human papillomavirus (HPV) vaccination pro-
gramme was introduced in England in 2008, with the aim of
reducing the incidence of cervical cancer.1 Initially, the pro-
gramme consisted of offering secondary school Year 8 girls
(12–13 years of age) three doses of vaccine during that aca-
demic school year. HPV vaccine coverage in the academic
year 2012/13 was 90.9% for at least one dose, 89.6% for
two doses and 86.1% for three doses.2
In March 2014, the Joint Committee on Vaccination and
Immunization (JCVI) recommended a change from a three
to a two-dose schedule based on evidence that two doses of
HPV vaccine given at least 6 months apart provided long-
lasting protection against HPV infection.2,3 This schedule
change was implemented in September 2014 using two
different delivery models: (i) two doses administered in
school Year 8, (ii) one dose in each of school Years 8 and 9.
The ﬁrst complete HPV vaccine coverage ﬁgures for the
two-dose schedule showed that there had been a slight
decline in coverage in England with 85.1% of teenage girls
completing the recommended two-dose course in 2015/16
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compared to 86.7% of Year 9 girls completing the three-
dose course in 2013/14.4 This was unexpected given the
reduction in number of doses and increased capacity for
school-based immunization delivery. Two-dose coverage
rates for Year 9 girls also varied signiﬁcantly across different
local authorities, ranging from 43.7% to 99.1% in 2015/16.4
This downward trend continued in 2016/17 when 83.1% of
Year 9 females completed the two-dose HPV vaccination
course.5
A number of studies have investigated acceptability and
barriers to access to HPV vaccine from the adolescents’ per-
spective.6,7 A review of organizational factors in the delivery
of school-based vaccination programmes in high-income
countries highlighted key factors of performance that
included staff capacity and skills, and the central role of the
school nurse; school leadership to support the vaccination
programme; communication with parents about the purpose
of vaccination and obtaining parental consent; and practical
aspects of clinic organization and delivery.8 Few studies con-
trast different service delivery strategies and explore how
organizational factors relate to programme performance.
The purpose of this service evaluation was to examine
whether service-related factors may have contributed to a
downward trend in adolescent girls’ HPV vaccination cover-
age and identify best practices from the perspectives of ser-
vice providers and commissioners.
Methods
Study population, recruitment and sampling
This service evaluation was conducted in six local authorities
covered by three Screening and Immunization Teams (SIT)
in England: South West (Cornwall, North Somerset, Bristol),
North Central Midlands (Lincolnshire, Leicester), and South
Central Midlands (Luton) (Table 1). This sampling frame was
determined in collaboration with PHE investigators. We
included areas that; (i) delivered either the two doses of vac-
cine in school Year 8 and areas that delivered the ﬁrst dose in
Year 8 and the second dose in Year 9. (ii) were geographically
and socio-demographically diverse, (iii) had a range of HPV
coverage rates, and commissioned different types of provi-
ders (e.g. school nurses, and immunization teams).
We invited individuals working at commissioning and ser-
vice delivery level (Box 1) to participate by emailing them a
study information letter. Respondents who expressed inter-
est in participating were contacted. An initial phone call was
arranged for a researcher to explain the study and answer
any questions. If the respondent was still interested in par-
ticipating, a time and place for the interview was arranged.
Researchers visited study participants at their place of work,
discussed what participation would involve and obtained
written informed consent prior to conducting interviews and
observations. The consent process included an explanation
on how we would protect participants’ conﬁdentiality.
Data collection
This involved individual and group interviews and an obser-
vation of a school immunization session (documented in ﬁeld
notes). The interviews were conducted by two investigators;
TC focused on the South West and Central Midlands SITs
areas and PP on the North Midlands SIT area. A semi-
structured interview (SSI) approach was adopted to enable
the interviewer to cover pre-deﬁned topics and allow the
exchange to be shaped by interviewees’ roles, responsibilities
and experiences (Box 2 and 3). The interview topic guides
were pre-tested with the support of an immunization provider
and a commissioner from a non-participating area. Interviews
were mostly conducted face to face, or by telephone.
Interviews were audio-recorded and transcribed verbatim.
Data analysis
The transcripts were downloaded into QSR International’s
NVivo 11 qualitative data analysis management software pro-
gramme. PP & TC read and annotated the transcripts from
their respective SIT site interviews and held regular data syn-
thesis meetings with SMJ to develop and reﬁne the coding
framework. The approach to data analysis was thematic and
involved a combination of deductive and inductive coding.10
Box 1 Targeted participants
Commissioning level Service delivery level
• NHS England Public Health Commissioners
• Screening and Immunization Leads
• Immunization managers
• Immunization coordinators with responsibility for school-aged immunizations
• Service provider organization administrators
• Service provider nursing leads
• Nurses who provide the vaccines in schools
• Service provider data administrators
• Child Health Information Service Managers
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This consisted of organizing the data under the pre-deﬁned
topic areas from the interview guides and then exploring this
data inductively to identify the key themes and associated
sub-points. The transcripts from service commissioners and
providers were analysed together to explore the interactions
between these actors, although where participants recounted
separate experiences this was noted. Some interviewees were
contacted again to address gaps in information and provide
clariﬁcations. At the ﬁnal stage of analysis, the ﬁndings were
discussed with co-investigators from Public Health England.
Findings
Study participants
Seven immunization programme commissioners and 32 ser-
vice providers took part in an individual or a group SSI
between May-August 2017. These exchanges lasted between
20–90 minutes. In one of the SIT areas (South West) a
researcher also observed a school immunization session
because the timing coincided with data collection. This was
not the case at the other research sites.
Analytical themes
Five themes were deﬁned in relation to programme service
delivery and three relating to data management. The HPV
immunization programme service delivery themes are: staff
skill mix, delivery teams and the role of commissioners;
working with schools; information and consent logistics;
immunization session logistics; and addressing concerns and
negative messages. The HPV immunization programme data
management themes are: accurate cohort numbers; advan-
tages of automated and real-time database systems; and an
effective data management team.
Hpv immunization programme service delivery
Staff skill mix, delivery teams and the role of
commissioners
Staff delivering the school-aged immunization programme
varied (Table 1). Key differences between local authorities
were the mix of staff (e.g. number of administrators, school/
immunization nurses, immunization leads/managers) and
whether vaccines were provided as part of a ‘broader school
nursing service’ or by a ‘stand-alone immunization team’.
Participants situated within the former noted that the com-
peting priorities of their role had an impact on their capacity
to manage the immunization programme, although they
valued the direct contact with adolescents that immunization
sessions afforded. Immunization teams were able to focus
on providing a stand-alone service but highlighted the
importance of feedback loops to the school nursing service
where safeguarding concerns arose during immunization
contacts with adolescents.
‘At the moment, [the HPV vaccination programme] it’s sitting
within a wider programme 0-19 [years] and school nursing
broadly… we’ve got immunisations to deliver, but at the same time,
we’ve got emotional health and wellbeing work to do, we’ve got safe-
guarding work to do… which compete for the time.’ (Service
provider)
‘When I’ve said, ‘Is there anything else you’d like to ask?’… they’ve
said things like, ‘Yes, I’m really struggling with my sleeping at the
moment’… I’d rather have the quick ﬁve-minute chat and then give
them a little bit of signposting… if we’re there all day… let’s give
them a positive health contact. Let’s give them the opportunity.’
(Service provider)
Box 2 Topic areas for commissioners
• Types of provider (Community trust, social or private enterprise)
• Commissioning arrangements and contracts
• School-aged immunizations
• Process of working with providers
• Facilitators and barriers to commissioning school aged
immunization
• Performance of the HPV vaccine programme across LAs/
Providers
• Changes in the provider landscape, delivery models, data
collection procedures since 2014
Box 3 Topic areas for service providers
• Roles and team set up
• Delivering the HPV vaccine programme within the context of the
wider school immunization and health programme (changes in
schedules, addition of new vaccines)
• Contextual factors and vaccine acceptability
• Call and recall systems, mop up strategies
• Contracting, submitting tenders, agreeing deliverables,
communication with commissioners
• HPV service delivery models: delivery model A (dose1 year 8,
dose 2 year 9) and delivery model B (both doses in year 8)
• Engagement and communication with schools, girls and their
parents/guardians, and related consent procedures
• Data management systems and data ﬂow (data collection,
recording of vaccination status, sharing data, data quality, and
communication)
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Planning and administration were highlighted as key to
successful delivery by the majority of interviewees. Service
provider teams that included designated, experienced admin-
istrators and data management staff were better placed to
manage the increasing schedule of school-aged vaccines
(inﬂuenza, HPV, teenage boosters and Men ACWY) and
work with schools to provide these immunization pro-
grammes within the relevant schools years. Retaining experi-
enced and suitable trained nurses and administrative staff
was however also reported as a challenge by service provider
leads.
Close collaboration between commissioners and provi-
ders, setting clear expectations and resolving issues together,
was thought to lead to effective service delivery.
Working with schools: facilitating programme delivery
Speciﬁc named contacts within schools and named counter-
parts in immunization teams helped establish good working
relationships with schools. Service providers stated that this
helped promote the vaccination programme, facilitated session
coordination and improved the percentage of consent forms
returned, especially where schools were actively involved in
chasing unreturned forms.
‘Some schools are very good and get a very good response… we tend
to ﬁnd it’s the ones that have got a nominated person in the school.’
(Service Provider)
Information and consent logistics
According to interviewees, non-returned consent forms may
either not have been given to parents, or were not completed
by parents due to lack of time, misplacement, or hesitancy
about HPV vaccination. Some teams had adapted the PHE
information and consent form template, adding vaccine and
health history questions, immunization checklists and space
for post vaccination observations.
‘One of the biggest issues, is not getting the forms returned. So, it’s
not actually a positive refusal, but it’s not a positive consent either.’
(Service provider)
The logistics of forms passing through multiple ‘hands’
was an evident barrier and meant that students would some-
times turn up to immunization sessions without a completed
consent form. Some nurses would conﬁrm if the student
wanted to be immunized and try to contact the parent to
obtain permission to administer the HPV vaccine. This
Table 1 Study sites
Screening and
Immunization
Team (SIT)
Local
Authority
(LA) areas
Delivery model
(2016/17)
Type of providers
(2016/17)
Service delivery format
(2016/17)
Vaccination
coverage (2016/17)
Year 89
Vaccination
coverage (2016/17)
Year 99
NHS England
South West
Cornwall Two doses over
two academic
years
Community interest
company
Immunization team Dose 1:78.6% Dose 1:83.8%
Dose2:57.6%
North
Somerset
Two doses over
two academic
years
Community interest
company
Immunization team that
contracts school nurse
time
Dose 1:90.8% Dose 1:91.0%
Dose 2:83.0%
Bristol Two doses over
two academic
years
Partnership Mixture of school and
immunization nurses
Dose 1:76.4% Dose 1:82.3%
Dose 2:73.6%
NHS England
North Central
Midlands
Lincolnshire Two doses over
two academic
years
Community NHS Trust School nursing Dose1:81.6% Dose 1:87.5%
Dose 2:77.7%
Leicester Two doses over
one academic
year
Community NHS Trust Immunization team Dose 1:84.5%
Dose 2:72.9%
NHS England
South Central
Midlands
Luton Two doses over
one academic
year
Community NHS Trust
and NHS Foundation
Trust
Immunization team Dose 1:80.9%
Dose 2:73.9%
England Dose 1:87.2% Dose 1:88.8%
Dose 2:83.1%
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could be time-consuming and some areas were planning to
maximize form return by using e-consent systems or stream-
lining consent form dissemination (e.g. using school internet
portals).
Immunization session logistics
The observation revealed that sessions could be very busy,
with students lining up outside rooms where nurses set up
stations while trying to use screens to maintain individual’s
privacy. Nurses highlighted in interviews that the manage-
ment of these sessions beneﬁtted greatly from active
involvement of key school staff helping coordinate the
arrival of students and accompanying individuals when
necessary. Some schools also offered the option of using a
ﬁrst aid room for students with special needs or who needed
closer attention or counselling. Nurses reported that they
tried their best to provide ‘adolescent-centred care’ and take
note of health issues of concern either raised by students or
observed.
‘If we have young people that… are prone to feeling faint, prone to
feeling unwell… [we] say, ‘Come and see us when… it’s a bit qui-
eter and then we can give you a bit more time… if the schools can
identify them to us, maybe we could administer their vaccine in…
the ﬁrst aid room and do it with more privacy.’ (Service provider)
Addressing concerns and negative messages
In December 2016, a UK-based day time television inter-
view with Melinda Messenger, a presenter and former glam-
our model, sparked social media discussion about the safety
of the HPV vaccine.11 A few interviewees stated that this
had resulted in some vaccine hesitancy amongst parents.
Although not presented as a major challenge, interviewees
highlighted the need for nurses to be prepared (receive regu-
lar training and have sufﬁcient access to informational mate-
rials) to pre-empt, acknowledge and address parents’
concerns whilst providing information about the beneﬁts
and risks of the vaccine. Several participants noted the
importance of these discussions.
‘I have had a few [parents] that have been thinking they’re going to
say no [to HPV vaccine], but then we’ve had a conversation and
it’s actually allayed their fears and… they actually go ‘okay, yes,
we’ll have it.’’ (Service provider)
HPV immunization programme data management
Accurate cohort numbers
Interviewees stated that it was key to obtain accurate class
lists in advance (ideally before the start of the new school
year) of the vaccination programme starting, for the team to
effectively plan vaccination activities.
‘To get your cohort numbers correct in the beginning, is the key to
starting a good programme basically… you’re not going to get your
coverage right, are you, unless you actually have got your denomin-
ator right in the beginning.’ (Service provider)
The migration of adolescent girls between schools and
geographies was reported as difﬁcult to manage, since it
could result in class list inaccuracies, incorrect numerators or
denominators and inaccurate vaccination coverage statistics.
Any movement in the time span between the ﬁrst and
second dose of the HPV vaccine made it particularly difﬁ-
cult to trace and ensure adolescent girls were fully protected
against HPV infection. Service providers who used a one
year delivery model (two HPV vaccines in school Year 8)
noted that there was less movement of children between
schools or areas. Real-time database systems also helped
manage this, as did troubleshooting meetings between com-
missioners, Child Health Information Services (CHIS) leads
and service providers, and regular communication with
General Practice.
Advantages of automated and real-time database
systems
Inputting and cleaning data in database systems was high-
lighted as labour intensive, especially the parts of the data
management system that are not automated.
‘There’s a lot of matching going on and it’s all a very manual pro-
cess… 18 000 mismatches that needed to be sorted manually and
some of them used to take 20 minutes each.’ (Service provider)
Database systems that are automated, with the ability to
conduct bulk processing, increase efﬁciency and accuracy.
When database systems are not real-time, delays between
records appearing on GP or school provider servers lead to
inaccurate data monitoring and could result in dual immun-
ization. For those on the CHIS system, this can also happen
when GPs do not send updated vaccination records to
CHIS in a timely fashion.
‘They both said I think we’ve had this done at the GP surgery. So,
we rang the GP surgery and they have had it done but that infor-
mation wasn’t on CHIS.’ (Service provider)
An effective data management team
The effectiveness of the data management team was
reported to be reliant on regular training, up-to-date system
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operating practices and effective support from the database
system and the software teams. If the data management
team were located together it was easier to implement
updates and changes to data management. Having dedicated
administrative staff within teams was also viewed as key to
effective programme delivery, as were good working rela-
tionships within the CHIS team, and between the CHIS and
the immunization team.
‘Teams are scattered over four bases so it’s not as easy to make very
sudden quick changes to processes, and then ensure that that’s com-
municated.’ (Service provider)
Discussion
Main ﬁndings of this study
This study sought to determine service-related factors that
may have contributed to the slight downward trend in HPV
vaccination coverage since 2014 and identify ‘good practice’
which could mitigate these.
Systematic planning and accurate data management sys-
tems was viewed as key for the successful service provision of
HPV vaccination, as well as close collaboration between com-
missioners, service providers and data system managers, pro-
active engagement with schools, and service providers being
equipped to respond to parental concerns. Organizational and
logistical aspects (e.g. skill-mix, obtaining consent, administra-
tive capacity in schools, data management) of school-based
vaccination were identiﬁed as factors which could inﬂuence
vaccination coverage.
What is already known on this topic
In their review, Perman and colleagues identiﬁed the inﬂu-
ence of programme leadership and governance, workforce
capacity, communication with parents and students, and
clinic organization on the effective delivery of vaccination
programmes in school-based settings.8 School staff commit-
ment and the quality of the relationship with a school nurse
was also highlighted as key for high uptake of HPV vaccin-
ation12 while delays in getting accurate and up-to-date class
lists was noted as an impediment.13 Lessons learned from
English service providers highlighted follow-up and remin-
ders for girls who missed immunization sessions and the
provision of additional opportunities for HPV vaccination
as factors associated with high coverage.5 One study has
shown preliminary evidence that incentivising vaccination in
school may improve vaccination uptake.14
Several studies have reported that school nurses felt bur-
dened by the workload associated with school vaccination
programmes15,16 while staff absenteeism and reduction in
school nursing capacity are associated with lower perform-
ance.5,15 In addition, speciﬁc challenges linked to the collec-
tion and interpretation of data have been reported by UK
vaccination providers. These include possible underestima-
tion of coverage due to incomplete accounting of ‘mop-ups’,
movement of students in and out of schools affecting the
numerators and/or denominators, unaccounted vaccination
at GP practices, the difﬁculty of combining data from mul-
tiple sources, and issues of inadequate data quality.5,17
What this study adds
Findings from this study were consistent with previously
cited factors of performance of school vaccination pro-
grammes. Our evidence emphasizes the increasing import-
ance of organizational delivery to the success of an
expanded vaccination schedule. It also highlights good prac-
tices for both providers and commissioners.
These include the need to engage with schools for the
long haul and the allocation of adequate administrative
resource to support effective interactions between immuniza-
tion teams, the school nursing service and schools. Service
providers also suggested ensuring that staff have sufﬁcient
experience and a good skill mix including planning, data
management, administrative and clinical skills for successful
service provision of HPV vaccination. Close collaboration
between commissioners, service providers, data system man-
agers and schools is needed to ensure that providers are well
equipped to respond to parental concerns. Finally, particular
attention was placed by service commissioners and providers
on developing and testing effective way to manage consent
of adolescents in school programmes.
Limitations of this study
This study aimed to explore the views and perspectives of
service commissioners and providers to identify factors con-
tributing to high- and under-performance of school-based
HPV vaccination. Although our sample was limited to three
SITs, care was taken to select geographical areas where; i.
differences in vaccine coverage across local authorities
existed and ii different delivery models were being used, in
terms of schedule (2 HPV doses given in one or two school
years) and organizational delivery (school nursing service or
standalone immunization teams). Obtaining data from com-
missioners, providers and data managers enabled us to tri-
angulate information and obtain a rich analysis of factors
affecting all levels of service delivery. We acknowledge that
interview participants may have been affected by social
desirability bias, giving responses expected to please the
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interviewers, although the use of a topic guide helped miti-
gate against this. Conducting more than one observation of
school immunization sessions would also have strengthened
our analysis.
Conclusions
England has achieved high coverage rates for HPV vaccine
compared with other European countries, and can be con-
sidered a front-runner among high-income countries for
school-based delivery of vaccines, given its expanded sched-
ule and strong performance. However, the slight decrease in
coverage for HPV vaccine coverage since 2014 combined
with interviewees’ reported views of the complexity of
organizational and logistical aspects of delivery may reﬂect a
growing imbalance between workload capacity and/or a
delivery model that needs to be adapted to its new expanded
scope. Learning from this rapid expansion of the school vac-
cination schedule should be of interest to other high-income
countries, and constitute an opportunity for public health
authorities to further improve the design of these vaccin-
ation programmes.
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